Abiopharma

(30% Negative) PYXIS ONCOLOGY, INC. (PYXS) Reports Q3 2026 Financial Results

(80% Positive) MINK THERAPEUTICS, INC. (INKT) Announces Enrollment Update for authorization Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(30% Negative) CREATIVE REALITIES, INC. (CREX) Reports Q3 2026 Financial Results

(30% Negative) MADISON SQUARE GARDEN SPORTS CORP. (MSGS) Reports Q3 2026 Financial Results

Form 8.3

New Form SCHEDULE 13G/A - CAVA GROUP, INC. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001218180-26-000008 <b>Size:</b> 16 KB

(99% Neutral) SPRINKLR, INC. (CXM) Announces Business Combination

(10% Negative) KARYOPHARM THERAPEUTICS INC. (KPTI) Reports Q3 2026 Financial Results

Financial Statements and Related Announcement: Half Yearly Results

Pariaros Symeon 🔴 sold 1.9K shares of EuroDry Ltd. (EDRY) at $39.98 Transaction Date: Aug 12, 2026 | Filing ID: 000005

New Form SCHEDULE 13G - RE/MAX Holdings, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001963860-26-000011 <b>Size:</b> 6 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000950103-26-012293 <b>Size:</b> 346 KB

Auxly Reports Second Quarter 2026 Results

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039761 <b>Size:</b> 702 KB

Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint